“The
Report EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast
to 2023 provides information on pricing, market analysis, shares,
forecast, and company profiles for key industry participants. -
MarketResearchReports.biz"
Renal
cell carcinoma (RCC) is a type of kidney cancer that originates in
the lining of the proximal convoluted tubule, a part of the very
small tubes in the kidney that transport waste molecules from the
blood to the urine. The condition is asymptomatic in its initial
stages, and as a result, people with RCC are often in the advanced
stages of the disease by the time it is discovered. The initial
symptoms of RCC often include blood in the urine, flank pain, a mass
in the abdomen or flank, weight loss, fever, hypertension, night
sweats, and a general feeling of being unwell. Kidney cancer is among
the 10 most frequently occurring cancers in Western countries.
View Report At
:http://www.marketresearchreports.biz/analysis/222343
GlobalData
epidemiologists forecast that there were 186,179 incident cases of
RCC in the 8MM in 2013, and the number of incident cases will grow
6.25% over the next decade to 302,449 incident cases. In 2013, there
were 593,228 prevalent cases of RCC in the 8MM. Each of the 8MM will
see an increase in prevalent cases over the 10-year forecast period.
This
forecast is supported by ageand sex-specific data for the incidence.
The oneto five-year relative survival data, which were used for the
five-year diagnosed prevalent cases forecast, are supported by
country-specific, population-based studies that are nationally
representative of the entire population in the respective markets.
Additionally, in each of the 8MM, the analysis is strengthened by the
use of a consistent methodology for the diagnosed incident cases
forecast, using regression techniques, and is based on 15 years of
country-specific historical data points pertaining to the ageand
sex-specific diagnosed incidence of RCC.
Download Sample copy of this
Report at : http://www.marketresearchreports.biz/sample/sample/222343
Scope
- The Renal Cell Carcinoma (RCC) EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for RCC in the eight major markets 8MM (US, France, Germany, Italy, Spain, UK, Japan, and urban China). It includes a 10-year epidemiological forecast for the diagnosed incident cases of RCC segmented by sex and age (in five-year age groups beginning at 20 years and ending at 85 years and older).
- GlobalData epidemiologists also forecast the five-year diagnosed prevalent cases of RCC in the 8MM. Additionally, the report provides the RCC diagnosed incident cases, segmented by the stage at diagnosis, for the 8MM.
- The RCC epidemiology report is written and developed by Mastersand PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
Reasons to buy
- Develop business strategies by understanding the trends shaping and driving the global RCC market.
- Quantify patient populations in the global RCC market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for RCC therapeutics in each of the markets covered.
Browse Latest News at
http://www.marketresearchreports.biz/articles
Table of Contents
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Upcoming Related Reports 7
3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors and
Comorbidities 9
3.3 Global Trends 10
3.3.1 Incidence 10
3.3.2 Survival Rates for RCC -
8MM 13
3.4 Forecast Methodology 14
3.4.1 Sources Used 16
3.4.2 Sources Not Used 19
3.4.3 Forecast Assumptions and
Methods, RCC Diagnosed Incident Cases 20
3.4.4 Forecast Assumptions and
Methods, RCC Five-Year Diagnosed Prevalent Cases 20
3.4.5 Forecast Assumptions and
Methods, RCC Clinical Stage at Diagnosis 21
3.5 Epidemiological Forecast
for RCC (2013-2023) 22
3.5.1 Diagnosed Incident Cases
of RCC 22
3.5.2 Age-Specific Diagnosed
Incident Cases of RCC 24
3.5.3 Sex-Specific Diagnosed
Incident Cases of RCC 26
3.5.4 Age-Standardized
Diagnosed Incidence of RCC 28
3.5.5 Diagnosed Incident Cases
of RCC by Clinical Stage at Diagnosis 30
3.5.6 Five-Year Diagnosed
Prevalent Cases of RCC 31
3.6 Discussion 32
3.6.1 Epidemiological Forecast
Insight 32
3.6.2 Limitations of the
Analysis 33
3.6.3 Strengths of the Analysis
33
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment